4 hours ago • pharmexec.com
FDA Approves Incyte’s Monjuvi for Relapsed or Refractory Follicular Lymphoma
4 hours ago • pharmexec.com
FDA Approves Incyte’s Monjuvi for Relapsed or Refractory Follicular Lymphoma6 hours ago • ajmc.com
FDA Approves Tafasitamab for Follicular Lymphoma6 hours ago • curetoday.com
Clinical Trial Corner: New Treatments in Leukemia, Lymphoma and Brain Cancers2025-06-21 • onclive.com
Conversations About BTK Inhibitors and CAR T-Cell Therapies Bridge Gaps in Leukemia and Lymphoma: With Alexey Danilov, MD, PhD2025-06-21 • stocktitan.net
Genentech’s Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell Lymphoma2025-06-20 • pharmacytimes.com
Tafasitamab-Cxix With Rituximab, Lenalidomide Approved by FDA for Relapsed/Refractory Follicular Lymphoma2025-06-20 • streetinsider.com
Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma2025-06-20 • cancernetwork.com
FDA Approves Tafasitamab Combo in R/R Follicular Lymphoma2025-06-19 • PR Newswire
RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin's Lymphoma2025-06-19 • clinicaltrialsarena.com
Lyell reports new clinical data from trial of large B-cell lymphoma therapy2025-06-18 • stocktitan.net
Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma2025-06-17 • biospace.com
Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi (lisocabtagene maraleucel)2025-06-17 • EIN Presswire
The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial2025-06-16 • globenewswire.com
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)2025-06-16 • PR Newswire
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)2025-06-15 • ajmc.com
Phase 3 POLARGO Trial Shows Survival Benefit of Polatuzumab-Based Regimen in R/R DLBCL: Matthew Matasar, MD2025-06-14 • fiercebiotech.com
J&J ties early-stage lymphoma CAR-T to 100% response rate in 10 patients2025-06-14 • onclive.com
Dr Dahiya on the Safety Profile of KITE-363 in Relapsed/Refractory B-Cell Lymphoma2025-06-13 • in.investing.com
ZYNLONTA-glofitamab combo shows 93.3% response rate in lymphoma trial2025-06-13 • PR Newswire
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma2025-06-13 • globenewswire.com
Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma2025-06-11 • PR Newswire
Foresight Diagnostics and Partners to Present Independent Validation Data for its CLARITY™ MRD Assay at the 2025 European Hematology Association (EHA) Congress and International Conference on Malignant Lymphoma (ICML)2025-06-06 • businesswire.com
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma2025-06-05 • koreabiomed.com
Vaxcellbio’s cancer drug delivers in canine lymphoma trial with improved response, safety2025-06-05 • prnewswire.co.uk
Follicular Lymphoma Market Growth Accelerates at a CAGR of 6% During the Forecast Period (2025-2034) Due to the Advancements in Targeted Therapies | DelveInsight2025-06-04 • businesswireindia.com
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD2025-06-02 • cgtlive.com
The Phase 2 Trial for CD5-Directed CAR-T MB-105 in R/R T-Cell Lymphoma2025-06-02 • cancernetwork.com
Novel CAR T-Cell Therapy Yields Responses in Relapsed/Refractory Lymphoma2025-05-31 • proactiveinvestors.com
Prescient begins PTX-100 Phase 2 Trial for rare lymphoma2025-05-31 • clinicaltrialsarena.com
ASCO25: MSD’s ADC candidate achieves 56.3% ORR in lymphoma trial3 hours ago • lowellsun.com
Townsend Water superintendent accused of ethics violation over $4.7M contract3 hours ago • bostonmagazine.com
Nantucket’s Textile Legacy Unfolds in New Exhibition3 hours ago • marketbeat.com
Hecla Mining Company (NYSE:HL) Receives Average Recommendation of "Hold" from Analysts3 hours ago • marketbeat.com
Steel Grove Capital Advisors LLC Purchases 30,748 Shares of Sonoco Products Company (NYSE:SON)3 hours ago • marketbeat.com
Advisor Resource Council Makes New $649,000 Investment in Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM)3 hours ago • marketbeat.com
Advocate Group LLC Buys 7,487 Shares of LyondellBasell Industries N.V. (NYSE:LYB)3 hours ago • indianexpress.com
Over 4% excess rainfall in June, sowing at a slow pace in Maharashtra3 hours ago • theglobeandmail.com
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months3 hours ago • hindustantimes.com
India’s health care investment moment3 hours ago • hindustantimes.com
Ludhiana: MC's road project ‘sans design approval’ narrows Buddha Nullah4 hours ago • harrowonline.org
Domestic abuse charity in Barnet faces strikes from workers4 hours ago • millenniumpost.in
China’s new era of dark factories3 hours ago • lowellsun.com
Townsend Water superintendent accused of ethics violation over $4.7M contract3 hours ago • bostonmagazine.com
Nantucket’s Textile Legacy Unfolds in New Exhibition3 hours ago • marketbeat.com
Brokerages Set G-III Apparel Group, LTD. (NASDAQ:GIII) Price Target at $27.805 hours ago • energyconnects.com
Russia’s Top Oil Executive Says OPEC+ Was Astute to Boost Output2025-06-21 • upstreamonline.com
Russian official touts cheap gas-fired power for domestic AI and cryptomining2025-06-21 • energyconnects.com
No Urgent Need for Key Producers to Aid Oil Market, Putin Says3 hours ago • indianexpress.com
Gujarat unveils electronics component manufacturing policy, offers Rs 12.5-crore aid for centres of excellence and research3 hours ago • hindustantimes.com
Haryana forms panel to crack down on illegal mining in Nuh3 hours ago • indiatoday.in
Karnataka minister pulls up own government over illegal mining: Systematic loot4 hours ago • harrowonline.org
Domestic abuse charity in Barnet faces strikes from workers4 hours ago • aberdeenlive.news
Significant progress on £38million project to replace water pipeline between Ellon and Peterhead4 hours ago • walesonline.co.uk
Renovation cottage in hidden village location with miles of famous countryside on the doorstepStay ahead with real-time headlines from top sources, categorized by sector and country.